Departments of General Internal Medicine Anatomical Pathology Pharmaceutical Services, Hiroshima University Hospital, Hiroshima, Japan.
Hepatol Res. 2012 Mar;42(3):310-20. doi: 10.1111/j.1872-034X.2011.00920.x. Epub 2011 Dec 19.
Patients with non-alcoholic steatohepatitis (NASH) frequently have many co-morbidities including essential hypertension, which is reported to increase vascular production of reactive oxygen species (ROS) and alter the hepatic anti-oxidant defense system. Since ROS play a role in the pathogenesis of NASH, it is hypothesized that hypertension modulates the hepatic oxidative status and influences the development of NASH. The aim of this study was to investigate the potential effects of hypertension on the progression of NASH.
Spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats as normotensive controls were fed choline-deficient (CD) diet for 5 weeks. Histological changes, messenger RNA (mRNA) expression and thiobarbituric acid reactive substances (TBARS) levels in the liver were assessed in each group.
Choline-deficient diet led to pronounced hepatic steatosis in SHR with an 8-fold increase of the hepatic triglyceride content, while there was no significant increase in WKY. These changes in SHR were associated with significant reduction in the expression of mRNA for peroxisome proliferator activated receptor α, acyl-CoA oxidase, microsomal triglyceride transfer protein, and apolipoprotein B100. Consistent with the significant reduction of hepatic superoxide dismutase activity and marked downregulation of the gene expression of hepatic antioxidant enzymes, the hepatic TBARS level and the plasma level of alanine aminotransferase were only increased in SHR on CD diet.
Spontaneously hypertensive rats receiving CD diet showed severe hepatic steatosis associated with reduction of hepatic anti-oxidant capacity, leading to increased hepatic oxidative stress and tissue damage. Accordingly, hypertension might have a potential effect on the progression of NASH.
非酒精性脂肪性肝炎(NASH)患者常合并多种合并症,包括原发性高血压,据报道原发性高血压可增加血管活性氧(ROS)的产生并改变肝脏抗氧化防御系统。由于 ROS 在 NASH 的发病机制中起作用,因此推测高血压会调节肝脏氧化状态并影响 NASH 的发生。本研究旨在探讨高血压对 NASH 进展的潜在影响。
自发性高血压大鼠(SHR)和 Wistar-Kyoto(WKY)大鼠作为正常血压对照,用胆碱缺乏(CD)饮食喂养 5 周。评估各组大鼠肝脏的组织学变化、信使 RNA(mRNA)表达和硫代巴比妥酸反应物(TBARS)水平。
胆碱缺乏饮食导致 SHR 出现明显的肝脂肪变性,肝甘油三酯含量增加 8 倍,而 WKY 无明显增加。SHR 的这些变化与过氧化物酶体增殖物激活受体α、酰基辅酶 A 氧化酶、微粒体甘油三酯转移蛋白和载脂蛋白 B100 的 mRNA 表达显著减少有关。与肝超氧化物歧化酶活性显著降低和肝抗氧化酶基因表达明显下调一致,只有 SHR 在用 CD 饮食时,肝 TBARS 水平和血浆丙氨酸氨基转移酶水平才会升高。
接受 CD 饮食的自发性高血压大鼠表现出严重的肝脂肪变性,伴有肝抗氧化能力降低,导致肝氧化应激和组织损伤增加。因此,高血压可能对 NASH 的进展有潜在影响。